Your Skin Is Dry Despite Moisturizing. Your Genes May Be Blocking Omega-3.

FADS1 produces the enzyme delta-5 desaturase, which catalyzes the final conversion step in the omega-3 pathway. Without it working properly, your body gets stuck with intermediate fatty acids (EPA precursors) that your skin cells can’t use effectively.

The FADS1 rs174537 variant, carried by roughly 30 to 40 percent of people with European ancestry, reduces delta-5 desaturase activity. If you carry this variant, your conversion of plant-based omega-3 into the DHA your skin membranes need drops by 40 to 60 percent. You can eat all the flaxseed and walnuts you want; your cells simply won’t convert it efficiently.

You notice this as persistently dry skin that responds poorly to moisturizers, a tendency toward eczema-like flaking, and skin that feels tight and uncomfortable no matter how much you hydrate. Some people also report slower wound healing or a pattern of minor infections in small cuts.

FADS2 produces delta-6 desaturase, the enzyme that catalyzes the very first step of converting plant omega-3 (ALA) into longer-chain, active forms. It’s the rate-limiting step: if it doesn’t work well, everything downstream suffers.

The FADS2 rs1535 variant, present in approximately 30 to 40 percent of the population, reduces delta-6 desaturase activity and can impair the entire conversion pathway. People with this variant often can’t efficiently convert plant-based omega-3 no matter how much they consume. Your dietary ALA piles up unused, while your tissues become progressively deficient in EPA and DHA.

On a day-to-day level, you experience dry, dull skin that ages faster than expected, weak skin barrier function (sensitivity to cold, wind, or irritating ingredients), and often poor response to topical treatments because the underlying problem is cellular, not surface-level.

PPARG (peroxisome proliferator-activated receptor gamma) is a nuclear receptor that acts as a master switch for metabolic inflammation and skin cell health. It directly regulates how skin cells differentiate, repair, and maintain their lipid barrier. PPARG activation is what many skin medications (like rosiglitazone) target because it’s so powerful.

PPARG variants, which vary by ethnicity and specific SNP, are associated with altered inflammation and reduced skin barrier lipid production. People carrying certain PPARG variants often have exaggerated skin inflammation and impaired ability to produce the ceramides and lipids that hold the skin barrier together. This creates a vicious cycle: inflamed, dry skin that becomes more permeable, allowing more irritants in, which triggers more inflammation.

You notice this as skin that reacts strongly to products, environmental changes, and even weather, with chronic dryness and itching that feels inflammatory rather than just dehydrated. Your skin may also show signs of dermatitis or a red, reactive appearance.

The VDR gene produces the vitamin D receptor protein, the critical gatekeeper that allows vitamin D to signal inside your skin cells. Vitamin D is not just a bone nutrient; it’s an immune signal that tells your skin to produce antimicrobial peptides, reduce inflammation, and strengthen the skin barrier. Without proper VDR function, vitamin D can’t do its job.

VDR variants (BsmI, FokI, TaqI), carried by 30 to 50 percent of the population depending on ancestry, reduce the efficiency of vitamin D receptor binding. You can supplement with vitamin D, test normal on bloodwork, and still be functionally vitamin D deficient at the cellular level because your skin cells can’t absorb it. This is especially true for the FokI ff variant, which produces a shorter receptor protein that’s more transcriptionally active but less stable.

Your skin shows this as chronic dryness that worsens in winter or in climates with low sun exposure, frequent infections or slow healing, and a tendency toward eczema or psoriasis-like patches. Many people also notice their skin improves significantly during periods of sun exposure but crashes again when they’re indoors or in winter.

MTHFR produces the enzyme methylenetetrahydrofolate reductase, which converts B vitamins into the methylated forms your cells need for DNA repair, skin cell renewal, and immune function. Methylation is the on-off switch for gene expression, and if it’s sluggish, your skin cells can’t renew efficiently.

The MTHFR C677T variant, carried by approximately 40 percent of people with European ancestry, reduces enzyme efficiency by 40 to 70 percent. Even with adequate B vitamin intake, your skin cells may be functionally B-vitamin deficient because you can’t recycle them into active forms. This slows collagen synthesis, impairs skin barrier repair, and reduces your cells’ ability to fight oxidative stress.

On a practical level, you experience slow skin recovery (wounds heal sluggishly), a tendency toward oxidative stress-related aging (sun damage, wrinkles, loss of elasticity), and skin that feels dull and inflamed no matter how much antioxidant cream you apply. Many people also notice acne, eczema, or rosacea flares, because inflammation control depends on methylation.

APOE produces apolipoprotein E, the protein that transports lipids (including cholesterol, triglycerides, and fatty acids) throughout your body and into your cells. Without proper APOE function, lipids that your skin cells need to rebuild their membranes don’t reach them efficiently, even if you’re eating them.

APOE has three common variants (E2, E3, E4), with different prevalences across ancestry groups. Carriers of the APOE4 allele have altered lipid handling and are more susceptible to impaired lipid delivery to tissues. People with APOE4, carried by roughly 15 to 25 percent of the population depending on ancestry, often struggle to deliver dietary omega-3 and omega-6 to skin cells, leaving their skin deficient despite adequate intake. This becomes more pronounced with age.

You notice this as difficulty improving skin quality even with high-quality supplements, a pattern of dry or aging skin that runs in your family (suggesting genetic lipid handling), and sometimes elevated cholesterol or triglycerides even on a healthy diet. Your skin may also be particularly reactive to dietary changes because your lipid delivery system is inherently less efficient.